Purpose: Osteoarthritis (OA) is the most common degenerative disease of the joint. Knockout mice have been a very powerful tool to elucidate the pathogenesis of OA. However, selectively deleting genes in adult animals in a tissue or time specific manner, still remains challenging. Here we have generated a conditional knockout mouse to study the role of activin A in a murine model of OA. Activin A is strongly regulated in human OA and is essential for normal musculoskeletal development (the constitutive knockout is neonatal lethal). Methods: Activin A floxed mice (Actf/f) were crossed with a line expressing Cre recombinase driven by the human ubiquitin promoter and controlled by a Tamoxifen-sensitive modified estrogen receptor (UbcCreERT2). The resulting mice (UbcCreERT2/Actf/f) were treated with Tamoxifen (TM) on 3 consecutive days at either 4 weeks (for cartilage injury studies), 8 weeks (for OA studies) or 10 weeks (for other studies) to create pan tissue activin A deletion. Activin A messenger RNA production was determined by real time PCR. Activin A protein secretion was measured by enzyme-linked immunosorbent assay (ELISA). Femurs and tibias were collected at 18 weeks for micro CT imaging. Results: In activin A conditional knockout (Act-cKO) mice, less than 10% of activin A mRNA was detected in cartilage, knee joints, spleen, liver and kidney compared with control levels (Act f/f or UbcCreERT2/Actf/f; no TM). ELISA showed that activin A secretion upon cartilage injury in Act-cKO hips was similarly reduced. For functional validation, micro CT analysis showed that 18 week old female Act-cKO had more trabecular bone volume, thickness and trabecular number than controls (p < 0.05). We also observed that Act-cKO showed a much delayed hair re-growth on the dorsal skin after hair removal compared with controls. Conclusions: We have successfully generated an activin A conditional knockout mouse and have validated the deletion at the mRNA and protein level in a number of tissues including cartilage. We have demonstrated functional loss of activin in bone by showing that these mice have increased bone mass, a phenotype that is predicted by other in vivo/vitro studies. The retarded hair re-growth phenotype in Act-cKO mice was in agreement with the fact that constitutive activin A knockout had no whiskers. We are currently awaiting the outcome of the OA experiments to see whether disease is modulated by lack of activin A. Purpose: An acute inflammatory phase follows an injury to the knee joint and initiates a cascade of biochemical events that can contribute to degeneration of the cartilage. Cartilage degeneration after injury is central in the development of posttraumatic osteoarthritis (PTOA) -a debilitating disease that is increasingly affecting active younger individuals. It is currently believed that inflammation following intraarticular bleeding from joint injuries could be a cause in the development of PTOA. To study the effects of inflammation alone within the joint, an injury model was developed in which tissue structures responsible for joint function and stability were not directly impacted. Preliminary evidence in this rabbit model of intra-articular bone injury, intended to simulate posttraumatic hemarthrosis, has shown what appears to be an acute inflammatory phase that resolves after surgery and yet still results in the development of significant PTOA. Therefore, we hypothesize that if insult to the joint increases the expression level of acute inflammatory mediators that expose the cartilage to injury then an intervention that inhibits acute inflammation (dexamethasone) will have positive outcomes on cartilage health within this rabbit bone injury model. Dexamethasone (dex) is a glucocorticoid with potent anti-inflammatory properties that has been widely adopted for clinical use (e.g. in the treatment of rheumatoid arthritis, asthma, and various cancers). Methods: Skeletally mature adult female rabbits aged 52 weeks (n ¼ 18) were used in this study. Six animals were not subjected to any interventions and served as un-operated controls. The remaining 12 were all subjected to a femoral notch drill surgery following the guidelines of our institutional animal care facility. Of this group, six rabbits were treated with one intra-articular injection of Dex (0.5 mg/ kg) at the time of surgery. As surgical controls, the remaining 6 animals were subjected to drill surgery, but did not receive any dexamethasone treatment. Animals were sacrificed at 9 weeks post surgery. Histological assessment was completed by two blinded observers using a modified Mankin protocol. qPCR was used to analyze the mRNA levels for select anabolic and catabolic molecules, and values were normalized to 18S mRNA. Kruskal-Wallis with Dunn's multiple comparisons test were used to investigate treatment group differences (significance accepted at p 0.05). Results: Histological evaluations ( Figure 1A ) revealed that at 9 weeks post surgery the cartilage on the tibial plateaus of the drill animals was significantly more damaged than that of the un-operated controls and the animals that received the dex treatment after injury. There were no significant differences between the tibial plateau cartilage of the normal and drill þ dex treatment groups, suggesting a positive role for dexamethasone. Furthermore, the mRNA analysis ( Figure 1B ) revealed that even a single dose of dexamethasone at the time of surgery, was sufficient to attenuate the expression of degradative proteinase matrix metalloproteinase 3 (MMP-3), proteoglycans such as versican and biglycan as well as anabolic marker collagen type II (Col-II) in tibial plateau cartilage. Conclusions: Even in the absence of severe biomechanical changes, the cartilage of the tibial plateau is subject to degeneration in this model. This strongly suggests that initial biological changes are sufficient to drive many of the changes observed within the joint. The results of this study suggest that Dexamethasone treatment given at the time of drill surgery had a positive impact in reducing the degradation of the cartilage covering the tibial plateau. Interestingly, treatment with this steroid attenuated the mRNA levels for both anabolic and catabolic molecules. Purpose: In the pathogenesis of osteoarthritis (OA), several proteases including the MMP (matrix metalloproteinase) family and ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) family are thought to play a part in the early phase of cartilage degradation. Among them, MMP13 and ADAMTS5 are presumed to be the major players, and inhibition of those proteases has been demonstrated to prevent cartilage degradation in animal osteoarthritic models. Small interfering RNA (siRNA) silences specific genes by interfering with mRNA translation, and acts to modulate or inhibit specific biological pathways. siRNA has been proven to be beneficial in knocking down protease effects in vitro, but there are still unsolved problems before applying this method in vivo, due to the molecular instability and difficulty in transfecting siRNAs in vivo. Recently, chemically modulated siRNAs which do not require transfection agents or other additional techniques such as electroporation in transfecting into cells have been developed. These siRNAs can be applied simply to cells with low cellular toxicity, and is likely to be suitable for in vivo use. Previous studies have demonstrated that the effects of intra-articular injection of ADAMTS5 or MMP13 siRNA into the knee on the delay and attenuation of articular cartilage degeneration. However, the effect of the combined siRNA injection of these two proteases is not clear. Therefore, purpose of this sturdy is to examine the effect of administration of chemically modulated MMP13 siRNA alone or in combination with ADAMTS5 siRNA in a mice OA model. Methods: OA pathology was surgically induced to C57BL/6 mice by destabilization of the medial meniscus (DMM) method, by transecting the medial meniscotibial ligament under general anesthesia. Three different siRNA injections against the DMM model were evaluated. MMP13 siRNA group was injected chemically modulated MMP13 siRNA one week after DMM surgery. Combined siRNA group was injected ADAMTS5 siRNA three days after the surgery and MMP13 siRNA four days later. Control siRNA group was injected non targeting siRNA which does not target to any gene. Histological assessment of articular cartilage at 8 weeks post DMM surgery was conducted to assess the effect of siRNA injections in osteoarthritis progression, according to the OARSI recommendation for OA knee scoring in mice. Results: Fibrillation and loss of Safranin O staining of the cartilage surface were observed in control siRNA group. Improvement was observed in the histological score in both treated group compared to the control siRNA injected group. Especially in combined siRNA group, the score was lower than MMP13 siRNA group. Conclusions: Combined treatment with MMP13 siRNA and ADAMTS5 siRNA intra-articular injection can be expected to inhibit cartilage degradation at the early phase of OA development compared to treatment MMP13 siRNA alone.
COLLAGEN TYPE III DEPOSITION IN ARTICULAR CARTILAGE MAY BE A DISTINCTIVE BIOMARKER OF HIP OSTEOARTHRITIS
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Objective: To determine if collagen type III deposition in osteoarthritic articular cartilage is a significant contributor to the pool of collagen. Method and material: Site matched cartilage of 10 femoral heads from OA and fracture patients (reference cartilage) were examined. Femoral heads were obtained from surgery of total hip replacement due to OA and femoral neck fracture. Cartilage was pulverized and treated by achymotrypsin, an enzyme which selectively extracts damaged collagen. The amount of collagen in both the extract and the remaining residue has been analyzed by hydroxyproline assay. Another pulverized cartilage specimen was used for a proteomics approach which includes tissue extraction by guanidine hydrochloride (4M GuHCl), digestion and reversed phase separations coupled to tandem mass spectrometry for the identification and quantification of peptides. The peak areas of targeted collagen peptides were measured and compared between OA and fracture patients. Results: Amount of extracted pool of collagen in chymotrypsin extracted OA cartilage was 3 folds higher than reference cartilage. The amount of total collagen (based on hydroxyproline) in both groups did not differ statistically. Results: The split line patterns of patella, femur, and tibia were found to be consistent over seven knee joints harvested from New Zealand white rabbits allowing us to proceed to the next step of introducing cracks. Preliminary results show around 10% deeper indentations in cartilage cracked perpendicular to the split lines vs. intact cartilage with around 20% reduction in time to reach a steady-state plateau after stress relaxation (Figure 3 ).
